Drugs / INV-347
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07153172 | Aug 2025 → Sep 2027 expected | obesity disorder | Novo Nordisk A/S | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | INV-347 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07153172 ↗ |